Alan is the CEO at Receptor.AI, a drug discovery company he co-founded in 2021. He has used his skills in integrating AI, molecular simulations, and advanced experimental techniques to create the company's innovative hybrid intelligence drug discovery platform. He holds a PhD in data science education from Kyiv Polytechnic University, further solidifying his knowledge and expertise in the AI field.